BioSpace News Archive

The U.S. Food and Drug Administration, the Centers for Disease Control and Prevention (CDC), along with state and local partners, are investigating a multistate outbreak of E. coli O157:H7 likely linked to romaine lettuce.

Grand Opening Event debuting Artificial Intelligence-powered, virtual medical clinics inside Phoenix-area Safeway stores. Mayor Mark Mitchell to host ribbon cutting and make remarks.

Kewaunee Scientific Corporation announced today its Board of Directors declared a quarterly cash dividend of nineteen cents per outstanding share, payable on December 17, 2018 to stockholders of record at the close of business on December 4, 2018.

HITRUST CSF Certification and HITRUST Certification of the NIST Cybersecurity Framework validates Sandata is committed to meeting key regulations and protecting sensitive information.

Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced it has received ISO (International Standards Organization) 27001 certification of its Omnipod DASH™ System.

Mylan N.V. today announced that its U.S. based Mylan Pharmaceuticals business is conducting a voluntary nationwide recall to the consumer level of select lots of Valsartan-containing products, including six lots of Amlodipine and Valsartan Tablets, USP (including the 5mg/160mg, 10mg/160mg, and 10mg/320mg strengths), seven lots of Valsartan Tablets, USP (including 40 mg, 80 mg, 160 mg, and 320 mg strengths), and two lots of Valsartan and Hydrochlorothiazide Tablets, USP 320mg/25mg strength.

Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology company developing next-generation neuromodulators for use in treating aesthetic and therapeutic conditions, today announced that the Company will participate in two upcoming investor conferences.

Navitor Pharmaceuticals, Inc., a biopharmaceutical company developing innovative therapeutics targeting the activity of mTORC1, or Complex 1 of the mechanistic target of rapamycin, for neurological disorders and chronic diseases of aging, today announced that Thomas E. Hughes, Ph.D., Chief Executive Officer, will present a corporate overview at the 30th Annual Piper Jaffray Healthcare Conference.

Kewaunee Scientific Corporation (Nasdaq: KEQU) today announced that the Company plans to release its second quarter fiscal year 2019 financial results on Tuesday, December 4, 2018 after the close of trading.

Streamline Health Solutions, Inc. today announced it extended its banking agreement with Wells Fargo into its fiscal year 2020. The original agreement with Wells Fargo was to expire in November of 2019.